Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1994 Aug;97(Suppl 2):1–3. doi: 10.1111/j.1365-2249.1994.tb06251.x

Complement receptors and regulatory proteins: immune adherence revisited and abuse by microorganisms.

J P Atkinson 1, M Krych 1, M Nickells 1, D Birmingham 1, V B Subramanian 1, L Clemenza 1, J Alvarez 1, K Liszewski 1
PMCID: PMC1550360  PMID: 8070139

Full text

PDF
1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong C., Schubert J., Ueda E., Knez J. J., Gelperin D., Hirose S., Silber R., Hollan S., Schmidt R. E., Medof M. E. Affected paroxysmal nocturnal hemoglobinuria T lymphocytes harbor a common defect in assembly of N-acetyl-D-glucosamine inositol phospholipid corresponding to that in class A Thy-1- murine lymphoma mutants. J Biol Chem. 1992 Dec 15;267(35):25347–25351. [PubMed] [Google Scholar]
  2. Bessler M., Mason P. J., Hillmen P., Miyata T., Yamada N., Takeda J., Luzzatto L., Kinoshita T. Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene. EMBO J. 1994 Jan 1;13(1):110–117. doi: 10.1002/j.1460-2075.1994.tb06240.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bessler M., Mason P., Hillmen P., Luzzatto L. Somatic mutations and cellular selection in paroxysmal nocturnal haemoglobinuria. Lancet. 1994 Apr 16;343(8903):951–953. doi: 10.1016/s0140-6736(94)90068-x. [DOI] [PubMed] [Google Scholar]
  4. Birmingham D. J., Cosio F. G. Characterization of the baboon erythrocyte C3b-binding protein. J Immunol. 1989 May 1;142(9):3140–3144. [PubMed] [Google Scholar]
  5. Cooper N. R. Complement evasion strategies of microorganisms. Immunol Today. 1991 Sep;12(9):327–331. doi: 10.1016/0167-5699(91)90010-Q. [DOI] [PubMed] [Google Scholar]
  6. Dörig R. E., Marcil A., Chopra A., Richardson C. D. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell. 1993 Oct 22;75(2):295–305. doi: 10.1016/0092-8674(93)80071-l. [DOI] [PubMed] [Google Scholar]
  7. Farries T. C., Atkinson J. P. Evolution of the complement system. Immunol Today. 1991 Sep;12(9):295–300. doi: 10.1016/0167-5699(91)90002-B. [DOI] [PubMed] [Google Scholar]
  8. Hidaka M., Nagakura S., Horikawa K., Kawaguchi T., Iwamoto N., Kagimoto T., Takatsuki K., Nakakuma H. Impaired glycosylation of glycosylphosphatidylinositol-anchor synthesis in paroxysmal nocturnal hemoglobinuria leucocytes. Biochem Biophys Res Commun. 1993 Mar 15;191(2):571–579. doi: 10.1006/bbrc.1993.1256. [DOI] [PubMed] [Google Scholar]
  9. Hillmen P., Bessler M., Mason P. J., Watkins W. M., Luzzatto L. Specific defect in N-acetylglucosamine incorporation in the biosynthesis of the glycosylphosphatidylinositol anchor in cloned cell lines from patients with paroxysmal nocturnal hemoglobinuria. Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5272–5276. doi: 10.1073/pnas.90.11.5272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Iida Y., Takeda J., Miyata T., Inoue N., Nishimura J., Kitani T., Maeda K., Kinoshita T. Characterization of genomic PIG-A gene: a gene for glycosylphosphatidylinositol-anchor biosynthesis and paroxysmal nocturnal hemoglobinuria. Blood. 1994 Jun 1;83(11):3126–3131. [PubMed] [Google Scholar]
  11. Kalli K. R., Hsu P. H., Bartow T. J., Ahearn J. M., Matsumoto A. K., Klickstein L. B., Fearon D. T. Mapping of the C3b-binding site of CR1 and construction of a (CR1)2-F(ab')2 chimeric complement inhibitor. J Exp Med. 1991 Dec 1;174(6):1451–1460. doi: 10.1084/jem.174.6.1451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Klickstein L. B., Bartow T. J., Miletic V., Rabson L. D., Smith J. A., Fearon D. T. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis. J Exp Med. 1988 Nov 1;168(5):1699–1717. doi: 10.1084/jem.168.5.1699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Krych M., Clemenza L., Howdeshell D., Hauhart R., Hourcade D., Atkinson J. P. Analysis of the functional domains of complement receptor type 1 (C3b/C4b receptor; CD35) by substitution mutagenesis. J Biol Chem. 1994 May 6;269(18):13273–13278. [PubMed] [Google Scholar]
  14. Krych M., Hourcade D., Atkinson J. P. Sites within the complement C3b/C4b receptor important for the specificity of ligand binding. Proc Natl Acad Sci U S A. 1991 May 15;88(10):4353–4357. doi: 10.1073/pnas.88.10.4353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Manchester M., Liszewski M. K., Atkinson J. P., Oldstone M. B. Multiple isoforms of CD46 (membrane cofactor protein) serve as receptors for measles virus. Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2161–2165. doi: 10.1073/pnas.91.6.2161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Miyata T., Takeda J., Iida Y., Yamada N., Inoue N., Takahashi M., Maeda K., Kitani T., Kinoshita T. The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis. Science. 1993 Feb 26;259(5099):1318–1320. doi: 10.1126/science.7680492. [DOI] [PubMed] [Google Scholar]
  17. Miyata T., Yamada N., Iida Y., Nishimura J., Takeda J., Kitani T., Kinoshita T. Abnormalities of PIG-A transcripts in granulocytes from patients with paroxysmal nocturnal hemoglobinuria. N Engl J Med. 1994 Jan 27;330(4):249–255. doi: 10.1056/NEJM199401273300404. [DOI] [PubMed] [Google Scholar]
  18. Naniche D., Varior-Krishnan G., Cervoni F., Wild T. F., Rossi B., Rabourdin-Combe C., Gerlier D. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol. 1993 Oct;67(10):6025–6032. doi: 10.1128/jvi.67.10.6025-6032.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Nickells M. W., Atkinson J. P. Characterization of CR1- and membrane cofactor protein-like proteins of two primates. J Immunol. 1990 Jun 1;144(11):4262–4268. [PubMed] [Google Scholar]
  20. Norris J., Hall S., Ware R. E., Kamitani T., Chang H. M., Yeh E., Rosse W. F. Glycosyl-phosphatidylinositol anchor synthesis in paroxysmal nocturnal hemoglobinuria: partial or complete defect in an early step. Blood. 1994 Feb 1;83(3):816–821. [PubMed] [Google Scholar]
  21. Nowicki B., Hart A., Coyne K. E., Lublin D. M., Nowicki S. Short consensus repeat-3 domain of recombinant decay-accelerating factor is recognized by Escherichia coli recombinant Dr adhesin in a model of a cell-cell interaction. J Exp Med. 1993 Dec 1;178(6):2115–2121. doi: 10.1084/jem.178.6.2115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Reilly B. D., Makrides S. C., Ford P. J., Marsh H. C., Jr, Mold C. Quantitative analysis of C4b dimer binding to distinct sites on the C3b/C4b receptor (CR1). J Biol Chem. 1994 Mar 11;269(10):7696–7701. [PubMed] [Google Scholar]
  23. Takahashi M., Takeda J., Hirose S., Hyman R., Inoue N., Miyata T., Ueda E., Kitani T., Medof M. E., Kinoshita T. Deficient biosynthesis of N-acetylglucosaminyl-phosphatidylinositol, the first intermediate of glycosyl phosphatidylinositol anchor biosynthesis, in cell lines established from patients with paroxysmal nocturnal hemoglobinuria. J Exp Med. 1993 Feb 1;177(2):517–521. doi: 10.1084/jem.177.2.517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Takeda J., Miyata T., Kawagoe K., Iida Y., Endo Y., Fujita T., Takahashi M., Kitani T., Kinoshita T. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell. 1993 May 21;73(4):703–711. doi: 10.1016/0092-8674(93)90250-t. [DOI] [PubMed] [Google Scholar]
  25. Tartakoff A. M., Singh N. How to make a glycoinositol phospholipid anchor. Trends Biochem Sci. 1992 Nov;17(11):470–473. doi: 10.1016/0968-0004(92)90491-q. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES